COVID-19 Vaccine Among Actively-Treated People With Cancer: A Glimpse Into the Known Unknowns?
J Natl Cancer Inst
.
2022 Feb 7;114(2):169-171.
doi: 10.1093/jnci/djab175.
Authors
Astha Thakkar
1
,
Sanjay Mishra
2
,
Jeremy L Warner
2
3
4
Affiliations
1
Department of Medicine, Division of Oncology, Montefiore Medical Center, Bronx, NY, USA.
2
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
3
Department of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, TN, USA.
4
Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.
PMID:
34453849
PMCID:
PMC8826529
DOI:
10.1093/jnci/djab175
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Neoplasms* / drug therapy
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines
Grants and funding
P30 CA068485/CA/NCI NIH HHS/United States
P30 CA068485/CA/NCI NIH HHS/United States